Chester County News and Community Website
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced its financial results for the second quarter ended June 30, 2024, along with key business updates.
Cabaletta Bio Reports Q2 2024 Financial Results and Provides Business Update Read More PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has released positive preliminary clinical data from its Phase 1/2 trials of CABA-201, a new potential treatment option for patients with autoimmune …
Cabaletta Bio Reports Promising Early Results for New Autoimmune Disease Treatment Read More PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) this week unveiled promising updates on its clinical trials and financial standing for the first quarter ending March 31, 2024. The company’s …
Cabaletta Bio Reports Promising Advances in Autoimmune Disease Trials, Looks to Future Innovations Read More